Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06057714 · University of North Carolina, Chapel Hill

Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis

What this study is about

The purpose of this study is to look at lung ventilation in people with cystic fibrosis over time (1 year) using magnetic resonance imaging (MRI) with an inhaled contrast gas, and compare these measures to lung function assessed by spirometry and multiple breath nitrogen washout.

View original scientific description

The purpose of this study is to look at lung ventilation in people with cystic fibrosis over time (1 year) using magnetic resonance imaging (MRI) with an inhaled contrast gas, and compare these measures to lung function assessed by spirometry and multiple breath nitrogen washout. This study also looks at how these measures change in response to a pulmonary exacerbation and treatment (if applicable). Over the span of a year, participants would be asked to complete 3-5 visits to the University of North Carolina at Chapel Hill (UNC). with each lasting up to 4 hours. If participants do not have a pulmonary exacerbation during the year they would be asked to complete 3 visits (one at enrollment, a second roughly 2 weeks later, and the third approximately a year later). If participants do experience a CF pulmonary exacerbation they would complete 5 visits (Visit 1, Visit 2, two exacerbation visits with one before treatment and the other after, and Visit 3 at one year after Visit 1). Only one exacerbation per participant will be tracked. Participants are eligible for this study if they are 18 years old or older, have Cystic Fibrosis (CF) with mild lung disease (FEV1 \>/= 60%), and can undergo an MRI. There are no known benefits for participating in this study.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Subjects must be ≥18 years of age
  • Non-smokers (\<10 pack/year history and no active smoking in the past year)
  • Diagnosis of cystic fibrosis via standard sweat chloride/phenotypic features/genotyping
  • No use of supplemental oxygen
  • Stable lung function (within 10% of personal best in the last 6 months) with no pulmonary exacerbations in the past 4 weeks and baseline FEV1≥60% of predicted
  • Evidence of a personally signed and dated consent indicating that the subject has been informed of all pertinent aspects of the trial
  • Subjects must be willing and able to comply with scheduled visits and other trial procedures

Exclusion criteria

  • Subjects presenting with any of the following will not be included in the trial:
  • Active or past smokers or vapers with less than 1 year since quitting or \>10 pack-year smoking history
  • Unable to undergo a 3.0-Tesla MRI exam of the lungs and chest because of contraindications including
  • Occupation (past or present) of machinist, welder, or grinder;
  • Injury to the eye involving a metallic object
  • Injury to the body by a metallic object (bullet, bullet ball, shrapnel)
  • Presence of a cardiac pacemaker or defibrillator
  • Presence of aneurysm clips
  • Presence of carotid artery vascular clamp
  • Presence of neurostimulator
  • Presence of insulin or infusion pump
  • Presence of implanted drug infusion device that is not known to be MRI compatible (i.e., was placed outside of UNC or is older than 10 years)
  • Bone growth or fusion simulator
  • Presence of cochlear, otologic or ear implant
  • Any type of prosthesis (eye, penile, etc.)
  • Artificial limb or joint
  • Non-removable electrodes (on body, head or brain)
  • Intravascular stents, filters or coils
  • Shunt (spinal or intraventricular)
  • Swan-Ganz catheter
  • Any implant held in place by a magnet
  • Transdermal delivery system (e.g. Nitro)
  • An intrauterine device or diaphragm that is not MRI compatible
  • Tattooed makeup (eyeliner, lips, etc.) or tattoos covering \>25% of body surface area
  • Body piercings (must be removed before MRI)
  • Any metal fragments
  • Internal pacing wires
  • Metal or wire mesh implants
  • Hearing aid (remove before MRI) aa. Dentures (remove before MRI) bb. Claustrophobia
  • Unable to tolerate inhalation of gas mixture
  • Presence of facial hair that may interfere with the fit of the mask (and unwillingness to shave prior to each MRI)
  • Any changes in medications that may affect CF lung disease in the past 28 days, including any experimental therapies
  • Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or may interfere with the interpretation of trial results and, in the judgment of the investigator, would make the subject inappropriate for entry into this trial.
  • Pregnancy; women of childbearing potential must have a confirmed negative urine pregnancy test on the day of the MR scan, prior to the MRI scan.

Where

  • Chapel Hill, North Carolina

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Jul 2, 2026 · Source of record for eligibility and locations

📊
1 of 30 participants interested
3% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Chapel Hill

North Carolina

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Cystic Fibrosis Trials by City

Browse all cystic fibrosis clinical trials in these cities — not just this study.

Looking for Cystic Fibrosis Treatment in Chapel Hill?

Join others in North Carolina exploring innovative treatment options through clinical research

Cystic Fibrosis Treatment Options in Chapel Hill, North Carolina

If you're searching for Cystic Fibrosis treatment in Chapel Hill, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Chapel Hill and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Cystic Fibrosis. All study-related care is provided at no cost to participants.

Local Sites
1 locations in North Carolina
Now Enrolling
Up to 30 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Cystic Fibrosis?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Cystic Fibrosis

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Cystic Fibrosis Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06057714. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.